Related Experiment Video
Updated: Sep 3, 2025
08:02
In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells
Published on: September 23, 2021
2.6K
Tumor-Derived Membrane Vesicles: A Promising Tool for Personalized Immunotherapy.
Jiabin Xu1,2, Wenqiang Cao3, Penglai Wang1,2
1School of Stomatology, Xuzhou Medical University, Xuzhou 221004, China.
Pharmaceuticals (Basel, Switzerland)
|July 27, 2022
Summary
Tumor-derived membrane vesicles (TDMVs) offer a promising platform for personalized immunotherapy and vaccine development due to their unique properties. This review explores TDMV technology, highlighting its potential and challenges for clinical application.
Area of Science:
- Biomedical Engineering
- Immunology
- Oncology
Background:
- Tumor-derived membrane vesicles (TDMVs) are easily obtained and possess tumor-specific substances.
- Their unique cellular properties enable applications in drug delivery, membrane fusion, and vaccine development.
Purpose of the Study:
- To review recent advancements in TDMV technology.
- To explore the application of TDMVs in personalized immunotherapy and vaccine design.
Main Methods:
- Literature review of current research on TDMV technology.
- Analysis of TDMV properties and their relevance to immunotherapy.
Main Results:
- TDMVs serve as effective personalized vectors for vaccine design.
- TDMVs exhibit potential in drug loading and membrane fusion applications.
Conclusions:
- TDMV technology presents significant strengths for personalized immunotherapy.
- Addressing current challenges is crucial for translating TDMV applications from theory to clinical practice.
Related Concept Videos
01:27Tumor Immunotherapy
652
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
652
02:17The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
01:30Cancer Vaccines
502
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
502
02:50Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K